| abstract |
Disclosed are inhibitors of Plasmodium surface anion channel (PSAC) and their use to treat or prevent malaria in animals such as humans. The use includes administering an effective amount of an inhibitor or combination of inhibitors. An example of such an inhibitor is a compound of formula I, Or a pharmaceutically acceptable salt thereof, wherein R 1 to R 7 are as described herein. [Selection figure] None |